{"disease":{"id":"anaphylactic-reaction","name":"anaphylactic reaction"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04755881","title":"SHARED Study (Saguenay Hospitals Anaphylaxis Rule for Early Discharge)","phase":"","overall_status":"TERMINATED","enrollment_count":191,"lead_sponsor_name":"Université de Sherbrooke","has_results":false},{"nct_id":"NCT06405399","title":"Design, Implementation and Evaluation of the Guided Observer Role in Clinical Simulation","phase":"NA","overall_status":"COMPLETED","enrollment_count":123,"lead_sponsor_name":"Clinica Universidad de Navarra, Universidad de Navarra","has_results":false},{"nct_id":"NCT05028257","title":"Allergy and COVID-19 Vaccines","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":117,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT05404165","title":"Relevance of the Self-assessment of Skills for Self-administration of Adrenaline by Auto-injectors in Patients at Risk of Severe Anaphylactic Reaction (PacAdré)","phase":"","overall_status":"UNKNOWN","enrollment_count":56,"lead_sponsor_name":"University Hospital, Grenoble","has_results":false},{"nct_id":"NCT06065137","title":"Standardised Drug Provocation Testing in Perioperative Hypersensitivity","phase":"NA","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"University Hospital, Antwerp","has_results":false},{"nct_id":"NCT06013150","title":"Study of Inhaled DMC-IH1 and Intramuscular (EpiPen®) Epinephrine in Healthy Male and Female Participants.","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"De Motu Cordis","has_results":false},{"nct_id":"NCT05152901","title":"Study of Inhaled Epinephrine and Intramuscular Epinephrine Administered to Healthy Adults","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":23,"lead_sponsor_name":"De Motu Cordis","has_results":false},{"nct_id":"NCT06205134","title":"Comparative Bioavailability of Intranasal Epinephrine","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"Nasus Pharma","has_results":false}],"total":8},"guidelines":[],"source":"Drug Landscape verified database"}